Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zifeng Yang

Showing results (241-250 of 277) with videos related to

Pageof 28
Sort By:
Frontiers in Pharmacology|August 16, 2021
Isoforskolin Alleviates AECOPD by Improving Pulmonary Function and Attenuating Inflammation Which Involves Downregulation of Th17/IL-17A and NF-κB/NLRP3Chuang Xiao, Sha Cheng, Runfeng Li, et al.
Mbio|August 6, 2024
A decavalent composite mRNA vaccine against both influenza and COVID-19Yang Wang, Qinhai Ma, Man Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 5, 2020
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathwayQinhai Ma, Runfeng Li, Weiqi Pan, et al.
Journal of Dairy Science|March 7, 2025
Cullin 3 mitigates nonesterified fatty acid-induced oxidative stress in mammary epithelial cells: Involvement of BCL2/BECN1 and autophagyYifei Dong, Wenwen Gao, Kai Liu, et al.
Vaccines|October 27, 2022
Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman PrimatesQinhai Ma, Runfeng Li, Jianmin Guo, et al.
Scientific Reports|December 6, 2022
Containment of SARS-CoV-2 Delta strain in Guangzhou, China by quarantine and social distancing: a modelling studyZhiqi Zeng, Tong Wu, Zhijie Lin, et al.
Annals of Palliative Medicine|April 25, 2021
Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical studyXiaolong Xu, Junhua Zhang, Wenke Zheng, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failureZhenya Wang, Wei Shi, Taibo Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 19, 2021
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialKe Hu, Wei-Jie Guan, Ying Bi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variantsCun Li, Jingjing Huang, Yifei Yu, et al.
Pageof 28

Showing results (241-250 of 277) with videos related to

Sort By:
Pageof 28
Frontiers in Pharmacology|August 16, 2021
Isoforskolin Alleviates AECOPD by Improving Pulmonary Function and Attenuating Inflammation Which Involves Downregulation of Th17/IL-17A and NF-κB/NLRP3Chuang Xiao, Sha Cheng, Runfeng Li, et al.
Mbio|August 6, 2024
A decavalent composite mRNA vaccine against both influenza and COVID-19Yang Wang, Qinhai Ma, Man Li, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|September 5, 2020
Phillyrin (KD-1) exerts anti-viral and anti-inflammatory activities against novel coronavirus (SARS-CoV-2) and human coronavirus 229E (HCoV-229E) by suppressing the nuclear factor kappa B (NF-κB) signaling pathwayQinhai Ma, Runfeng Li, Weiqi Pan, et al.
Journal of Dairy Science|March 7, 2025
Cullin 3 mitigates nonesterified fatty acid-induced oxidative stress in mammary epithelial cells: Involvement of BCL2/BECN1 and autophagyYifei Dong, Wenwen Gao, Kai Liu, et al.
Vaccines|October 27, 2022
Immunization with a Prefusion SARS-CoV-2 Spike Protein Vaccine (RBMRNA-176) Protects against Viral Challenge in Mice and Nonhuman PrimatesQinhai Ma, Runfeng Li, Jianmin Guo, et al.
Scientific Reports|December 6, 2022
Containment of SARS-CoV-2 Delta strain in Guangzhou, China by quarantine and social distancing: a modelling studyZhiqi Zeng, Tong Wu, Zhijie Lin, et al.
Annals of Palliative Medicine|April 25, 2021
Efficacy and safety of Reduning injection in the treatment of COVID-19: a randomized, multicenter clinical studyXiaolong Xu, Junhua Zhang, Wenke Zheng, et al.
Frontiers in Cardiovascular Medicine|March 31, 2023
A high-throughput drug screening identifies luteolin as a therapeutic candidate for pathological cardiac hypertrophy and heart failureZhenya Wang, Wei Shi, Taibo Wu, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|April 19, 2021
Efficacy and safety of Lianhuaqingwen capsules, a repurposed Chinese herb, in patients with coronavirus disease 2019: A multicenter, prospective, randomized controlled trialKe Hu, Wei-Jie Guan, Ying Bi, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 17, 2023
Human airway and nasal organoids reveal escalating replicative fitness of SARS-CoV-2 emerging variantsCun Li, Jingjing Huang, Yifei Yu, et al.
Pageof 28